Individual patient data metamanalyses in cancer
1998

Individual Patient Data Meta-analyses in Cancer

Sample size: 40000 publication Evidence: high

Author Information

Author(s): M Clarke, L Stewart, J-P Pignon, L Bijnens

Primary Institution: ICRF Clinical Trial Service Unit, Radcliffe Infirmary, Oxford, UK

Hypothesis

The paper illustrates the importance of individual patient data meta-analyses in cancer research.

Conclusion

Individual patient data meta-analyses can provide more reliable assessments of cancer treatments and help avoid unnecessary treatments.

Supporting Evidence

  • Meta-analyses can reveal small but significant differences in treatment effects.
  • Individual patient data allows for more accurate subgroup analyses.
  • Long-term follow-up can uncover unexpected treatment benefits.

Takeaway

This study shows that looking at data from many cancer trials together can help us understand which treatments work best.

Methodology

The study involved systematic reviews and meta-analyses of individual patient data from randomized controlled trials.

Potential Biases

There may be risks of bias due to the reliance on data from individual trials, which can vary in quality.

Limitations

The paper does not address the potential biases in the individual trials included in the meta-analyses.

Participant Demographics

The study references data from over 40,000 women in trials for breast cancer.

Statistical Information

P-Value

0.02

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication